A new study reveals many benzodiazepine users are misinformed about the risks of withdrawal and experience devastating consequences.
Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.
With the chemical imbalance theory falling out of fashion, researchers examine the claim that psychiatry never truly endorsed it.
A new study found that taking antidepressants did not improve quality of life.
According to patient reports, SSRI antidepressants most frequently lead to the subjective experience of emotional blunting.
New research examines service user attitudes on discontinuing and reducing antipsychotic drugs.
New research reveals that patients are often not given fully informed consent before being prescribed antipsychotics.
Withholding antipsychotics may be beneficial for memory, the researchers write.
A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.
The prescribing of stimulants to preschoolers diagnosed with ADHD is on the rise, which is said to be an "evidence-based" practice. A review of that "evidence base" reveals that claims that ADHD is characterized by genetic and brain abnormalities are belied by the data, and that the NIMH trial of methylphenidate in this age group told of long-term harm.
Researchers argue that we need a paradigm shift away from the biomedical model of mental illness to one informed by political action and common sense.
Antidepressant trials with negative results are still more likely than not to either be misleadingly spun as positive or unpublished.
A study in JAMA Neurology finds that antidepressants do not reduce depression symptoms more than placebo in patients recovering from a stroke.
A review of research on antidepressant efficacy finds that an unfavorable risk-to-benefit ratio.
Researchers argue that common study methods for psychiatric drugs may inadvertently minimize withdrawal effects and inflate drug efficacy.
A new research article asserts that the overuse of psychiatric drugs may create neurobiological changes that hamper long-term mental health recovery.
Current long-term users of benzodiazepines and Z-drugs identify barriers and facilitators for discontinuation.
A trial in veterans who had survived a previous suicide attempt was stopped early because the drug was found to be no better than a placebo.
Meta-analysis finds that the placebo run-in methodology reduces the placebo effect and finds antidepressants to be less useful.
Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.